BCTX
Price
$3.55
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Capitalization
22.99M
SNPX
Price
$2.21
Change
-$0.09 (-3.91%)
Updated
May 22 closing price
Capitalization
3.07M
Interact to see
Advertisement

BCTX vs SNPX

Header iconBCTX vs SNPX Comparison
Open Charts BCTX vs SNPXBanner chart's image
Briacell Therapeutics Corp NEW
Price$3.55
Change-$0.00 (-0.00%)
Volume$2.42K
Capitalization22.99M
Synaptogenix
Price$2.21
Change-$0.09 (-3.91%)
Volume$4.27K
Capitalization3.07M
BCTX vs SNPX Comparison Chart
Loading...
BCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCTX vs. SNPX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCTX is a StrongBuy and SNPX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (BCTX: $3.55 vs. SNPX: $2.21)
Brand notoriety: BCTX and SNPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCTX: 12% vs. SNPX: 46%
Market capitalization -- BCTX: $22.99M vs. SNPX: $3.07M
BCTX [@Biotechnology] is valued at $22.99M. SNPX’s [@Biotechnology] market capitalization is $3.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $307B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCTX’s FA Score shows that 1 FA rating(s) are green whileSNPX’s FA Score has 2 green FA rating(s).

  • BCTX’s FA Score: 1 green, 4 red.
  • SNPX’s FA Score: 2 green, 3 red.
According to our system of comparison, SNPX is a better buy in the long-term than BCTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCTX’s TA Score shows that 5 TA indicator(s) are bullish.

  • BCTX’s TA Score: 5 bullish, 5 bearish.

Price Growth

BCTX (@Biotechnology) experienced а +18.33% price change this week, while SNPX (@Biotechnology) price change was -0.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.82%. For the same industry, the average monthly price growth was +7.45%, and the average quarterly price growth was -1.67%.

Reported Earning Dates

BCTX is expected to report earnings on Mar 12, 2025.

SNPX is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Biotechnology (+4.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCTX($23M) has a higher market cap than SNPX($3.07M). SNPX YTD gains are higher at: -36.314 vs. BCTX (-58.112). SNPX has higher annual earnings (EBITDA): -6.76M vs. BCTX (-27.19M). SNPX has more cash in the bank: 22.1M vs. BCTX (5.01M). BCTX (0) and SNPX (0) have equivalent revenues.
BCTXSNPXBCTX / SNPX
Capitalization23M3.07M749%
EBITDA-27.19M-6.76M402%
Gain YTD-58.112-36.314160%
P/E RatioN/A2.75-
Revenue00-
Total Cash5.01M22.1M23%
Total Debt27KN/A-
FUNDAMENTALS RATINGS
BCTX: Fundamental Ratings
BCTX
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCTX
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NGNE18.040.55
+3.14%
Neurogene
ANSS343.00N/A
N/A
ANSYS
SCHL17.44N/A
N/A
Scholastic Corp
UMBF102.37N/A
N/A
UMB Financial Corp
BIAF0.28-0.01
-2.72%
bioAffinity Technologies

BCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCTX has been loosely correlated with SNPX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BCTX jumps, then SNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCTX
1D Price
Change %
BCTX100%
N/A
SNPX - BCTX
35%
Loosely correlated
-3.86%
KROS - BCTX
33%
Poorly correlated
+0.85%
MDGL - BCTX
30%
Poorly correlated
-1.40%
AXON - BCTX
30%
Poorly correlated
N/A
LSB - BCTX
30%
Poorly correlated
+3.64%
More